BG106079A - Cyclocarbamate derivatives as progesterone receptor modulators - Google Patents

Cyclocarbamate derivatives as progesterone receptor modulators

Info

Publication number
BG106079A
BG106079A BG106079A BG10607901A BG106079A BG 106079 A BG106079 A BG 106079A BG 106079 A BG106079 A BG 106079A BG 10607901 A BG10607901 A BG 10607901A BG 106079 A BG106079 A BG 106079A
Authority
BG
Bulgaria
Prior art keywords
substituted
alkyl
alkoxy
aminoalkyl
alkynyl
Prior art date
Application number
BG106079A
Other languages
Bulgarian (bg)
Inventor
Puwen Zhang
Eugene Teferenko
Andrew Fensome
Jay Wrobel
James Edwards
Todd Jones
Christopher Tegley
Lin Zhi
III Horace FLETCHER
Original Assignee
Ligand Pharmaceuticals, Inc.
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by Ligand Pharmaceuticals, Inc., Wyeth filed Critical Ligand Pharmaceuticals, Inc.
Publication of BG106079A publication Critical patent/BG106079A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention provides compounds of formula wherein R1 and R2 may be single substituents or fused to form spirocycle or heterospirocycle ring; R3 is H, OH, NH2, C1 to C6 alkyl, substituted C1 to C6 alkyl, C3 to C6 alkenyl, substituted C1 to C6 alkenyl, alkynyl, or substituted alkynyl, CORC; RC is H, C1 to C3 alkyl, substituted C 1 to C3 alkyl, aryl, substituted aryl, C1 to C3 alkoxy, substituted C1 to C3 alkoxy, C1 to C3 aminoalkyl, or substituted C1 to C3 aminoalkyl; R4 is H, halogen, CN, NO2, C1 to C6 alkyl, substituted C1 to C6 alkyl, alkynyl, or substituted alkynyl, C1 to C6 alkoxy, substituted C1 to C6 alkoxy, substituted C1 to C6 alkoxy, amino, C1 to C6 aminoalkyl, or substituted C1 to C6 aminoalkyl; and R5 is selected from a trisubstituted benzene ring of a five or six membered ring with 1, 2 or 3 heteroatoms from the group including O, S, SO2 or NR6 and containing one or two independent substituents from the group including H, halogen, CN, NO2, amino, and C1 to C3 alkyl, C1 to C3 alkoxy, C1 to C33 aminoalkyl, CORF, or NRGCORF; or pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions using the compounds as antagonists of the progesterone receptor. 22 claims
BG106079A 1999-05-04 2001-11-02 Cyclocarbamate derivatives as progesterone receptor modulators BG106079A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
BG106079A true BG106079A (en) 2002-05-31

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106079A BG106079A (en) 1999-05-04 2001-11-02 Cyclocarbamate derivatives as progesterone receptor modulators

Country Status (19)

Country Link
EP (1) EP1173426A1 (en)
JP (1) JP2002543193A (en)
KR (1) KR20010114250A (en)
CN (1) CN1145618C (en)
AU (1) AU766428B2 (en)
BG (1) BG106079A (en)
BR (1) BR0010213A (en)
CA (1) CA2371726A1 (en)
CZ (1) CZ20013951A3 (en)
EA (1) EA004512B1 (en)
HU (1) HUP0201609A3 (en)
IL (1) IL146280A0 (en)
MX (1) MXPA01011286A (en)
NO (1) NO321361B1 (en)
NZ (1) NZ515355A (en)
PL (1) PL351127A1 (en)
SG (1) SG114650A1 (en)
SK (1) SK15912001A3 (en)
TR (1) TR200103286T2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510278A (en) * 2004-04-27 2007-10-30 Wyeth Corp method for producing compounds, product, and, compound
JPWO2006077821A1 (en) * 2005-01-19 2008-06-19 大日本住友製薬株式会社 Aromatic sulfone compounds as aldosterone receptor modulators
EP2210880B1 (en) * 2007-10-05 2015-08-26 Msd K.K. Benzoxazinone derivatives
CN111925353B (en) * 2020-08-31 2022-04-08 苏州大学附属第二医院 Preparation method of 2-thiophenecarbonitrile

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
WO1996019458A2 (en) * 1994-12-22 1996-06-27 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
EP0929533B1 (en) * 1996-10-02 2003-09-03 Bristol-Myers Squibb Pharma Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Also Published As

Publication number Publication date
TR200103286T2 (en) 2002-07-22
CN1145618C (en) 2004-04-14
NO20015378L (en) 2002-01-03
SK15912001A3 (en) 2002-06-04
HUP0201609A3 (en) 2002-12-28
SG114650A1 (en) 2005-09-28
CA2371726A1 (en) 2000-11-09
IL146280A0 (en) 2002-07-25
BR0010213A (en) 2002-02-19
EA004512B1 (en) 2004-04-29
CZ20013951A3 (en) 2002-05-15
AU766428B2 (en) 2003-10-16
JP2002543193A (en) 2002-12-17
NO20015378D0 (en) 2001-11-02
MXPA01011286A (en) 2003-07-14
HUP0201609A2 (en) 2002-08-28
CN1349517A (en) 2002-05-15
NZ515355A (en) 2004-02-27
KR20010114250A (en) 2001-12-31
AU4688600A (en) 2000-11-17
NO321361B1 (en) 2006-05-02
EA200101176A1 (en) 2002-04-25
EP1173426A1 (en) 2002-01-23
PL351127A1 (en) 2003-03-24

Similar Documents

Publication Publication Date Title
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
HUP0300565A2 (en) 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors, their use, process for their preparation and pharmaceutical compositions containing them
NO20004778L (en) Amide derivatives and nociceptin antagonists
HUP0300641A2 (en) Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions containing the same as the active ingredient
DE69310501T2 (en) CHINOLYLBENZOFURAN DERIVATIVES AS LEUKOTRIA ANTAGONISTS
WO2000066581A8 (en) Cyanopyrroles as progesterone receptor agonists
MXPA02012447A (en) Thrombin receptor antagonists.
BG102637A (en) Tropane derivatives, their preparation and application
DE69706112T2 (en) Substituted biphenyl or phenylpyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
DK0583485T3 (en) Ethanolamine derivatives with sympathomimetic and anti-pollakisuria effects
BG106080A (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
DK0902018T3 (en) 2- (arylpheny) amino-imidazoline derivatives
HUP0101469A2 (en) 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as alpha-adrenoceptor agonists with improved metabolic stability
CO5540322A2 (en) NEW HETEROCICLIC DERIVATIVES THAT INCLUDE A RING OF TETRAHYDROISOQUINOLINE AND PHARMACEUTICAL USE OF THE SAME
CO5160261A1 (en) SUBSTITUTED BIFENYL DERIVATIVES THAT ARE NK-1 ANTAGONISTS, THEIR SYNTHESIS PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BG106079A (en) Cyclocarbamate derivatives as progesterone receptor modulators
GEP20043221B (en) Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Pharmaceutical Composition Containing Them and Use Thereof for Treatment Progesterone-Related Maladies.
HUP0004671A2 (en) 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives and pharmaceutical compositions thereof
YU38498A (en) 2-(arylphenyl)amino-imidazoline derivatives
TWI265032B (en) Pharmaceutically useful kits comprising progesterone receptor modulators